Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06617741 · ClinicalTrials.gov registry record
Myasthenia Gravis Foundation of America Global MG Patient Registry
A clinical trial of Myasthenia Gravis, Generalized and Myasthaenia Gravis, sponsored by Myasthenia Gravis Foundation of America.
- Recruiting
- Registry status
- 3,800
- Enrollment target
- 1
- Study location
NCT06617741: Recruiting study of Myasthenia Gravis, Generalized and Myasthaenia Gravis, sponsored by Myasthenia Gravis Foundation of America.
NCT06617741 is a study of Myasthenia Gravis, Generalized and Myasthaenia Gravis that is actively recruiting participants, run by Myasthenia Gravis Foundation of America. The registered enrollment target is 3,800 participants, above the 71-participant average among 3 other Myasthenia Gravis, Generalized trials with a reported enrollment target (5252% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06617741, a study of Myasthenia Gravis, Generalized and Myasthaenia Gravis, is actively recruiting participants, sponsored by Myasthenia Gravis Foundation of America.
- RECRUITING
- Registry status
- 3,800 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are: * How and when are people with MG diagnosed? * What are the most common symptoms associated with MG? * What treatments are being used to treat MG? * What are the impacts of MG on activities of daily living, employment and quality of life? * What are the experiences with exacerbation, hospitalization and healthcare access for people with MG? Participants will answer a survey to enroll in the study, and be invited to fill out an update survey twice a year.
Primary Outcome
Whether the patient has a confirmed MG diagnosis.
Conditions Studied
Study Locations (1)
Massachusetts
- Myasthenia Gravis Foundation of America - Westborough
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,800 participants |
| Start Date | 2013-10-12 |
| Est. Completion | 2029-09-19 |
What NCT06617741 shows while recruiting
NCT06617741 is an observational study that tracks outcomes without assigning an intervention. Its 3,800 participants enrollment target places it among the larger protocols in the corpus, above the 71-participant average among 3 other Myasthenia Gravis, Generalized trials with a reported enrollment target (5252% higher).
The record links to 10 conditions, with Myasthenia Gravis, Generalized appearing as the primary indexed condition, and to 0 interventions.
NCT06617741 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06617741 about?
NCT06617741 is a clinical study titled "Myasthenia Gravis Foundation of America Global MG Patient Registry". The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are: * How and when are people with MG diagnosed? * What are the most common symptoms associated with MG? * What treatments ...
What is the current status of trial NCT06617741?
This trial is currently recruiting. The enrollment target is 3,800 participants. The study started on 2013-10-12. Estimated completion is 2029-09-19.
What conditions does trial NCT06617741 study?
This clinical trial studies the following conditions: Myasthenia Gravis, Generalized, Myasthaenia Gravis, Myasthenia Gravis Crisis, Myasthenia Gravis Exacerbations, Myasthenia Gravis, Ocular.
Who is sponsoring clinical trial NCT06617741?
This trial is sponsored by Myasthenia Gravis Foundation of America, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06617741 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis, Generalized
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
ACTIVE NOT RECRUITING · Phase 3
-
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
ACTIVE NOT RECRUITING · Phase 2
-
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI